Top Markets
Coin of the day
TCR2 Therapeutics Inc. TCR2 Therapeutics Inc.

TCR2 Therapeutics Inc.

TCRR
Rang în acțiuni #27038
TCR2 Therapeutics Inc. is a clinical-stage immunotherapy firm focused on... TCR2 Therapeutics Inc. is a clinical-stage immunotherapy firm focused on developing cutting-edge T cell receptor (TCR) therapies for cancer patients. The company's lead investigational treatment, gavo-cel, is a unique mono TCR Fusion Construct T cell (TRuC-T cell) designed to target mesothelin-positive solid tumors. This therapy is currently being evaluated in Phase I/II clinical trials for non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal mesothelioma, and cholangiocarcinoma. Furthermore, TCR2 Therapeutics has concluded preclinical development for TC-510, another TRuC-T cell specifically engineered to target mesothelin on solid tumors. They are also advancing TC-520, a CD70-targeting TRuC-T cell designed with fratricide resistance for treating renal cell carcinoma. Founded in 2015, the company, formerly known as TCR2, Inc. until its name change in November 2016, is headquartered in Cambridge, Massachusetts.
Preț acțiune
$1.48
Ultima sincronizare: 2023-05-31
Capitalizare de piață
$35.54M
Schimbare (1 zi)
-5.73%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează TCR2 Therapeutics Inc. (TCRR)

Categorie

Istoricul randamentului dividendelor pentru TCR2 Therapeutics Inc. (TCRR)
Randamentul dividendelor (TTM) pentru TCR2 Therapeutics Inc. (simbol acțiune: TCRR) la data de 2026 este: 0
Randamentul mediu al dividendelor în ultimii 5 ani: 0.00%
Istoric al randamentului dividendelor pentru TCR2 Therapeutics Inc. (TCRR) între 2026 și 2026
Randamentul dividendelor la sfârșitul fiecărui an (TTM)
An Randamentul dividendelor Schimbă
Nu sunt suficiente date pentru perioada selectată.
Randamentele dividendelor (TTM) pentru companii similare sau concurente
Companie Randamentul dividendelor Țara
0.00%
US
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH